Amlobika Tablet 5/20mg

Adult dose

This drug is taken once daily with water, irrespective of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg monotherapy. - 10/20 mg: Olmesartan medoxomil 20 mg alone for patients not adequately controlled.

Child dose

Safety and efficacy for patients under 18 years of age have not been established.

This drug can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the main ingredients or similar class medications, women who are pregnant or nursing, patients with severe liver dysfunction, severe aortic stenosis, obstructive biliary disease, patients on dialysis, those in shock, and certain diabetic patients should not take this medication. When this drug is initially administered to patients who are depleted of fluids or salts, it may cause a significant drop in blood pressure, so careful monitoring of the patient's condition is required, and appropriate measures should be taken if necessary. Acute hypotension may occur after taking this medication due to vasodilation, so patients with severe aortic stenosis should use caution. Use this medication cautiously in patients with severe heart disease or congestive heart failure, and those with impaired renal function should also be careful. Patients with impaired liver function may experience slower metabolism of this drug and should use caution while taking it. Side effects such as dizziness, headaches, low blood pressure, cough, digestive disorders, skin rashes, etc., might occur. If unusual symptoms appear, consult a doctor. In particular, women who are pregnant or planning to become pregnant should switch to other established safe antihypertensives, and if this drug was taken during pregnancy, tests are needed to check for any fetal abnormalities. Breastfeeding women are advised to discontinue breastfeeding or stop taking the medication since it may be transmitted through breast milk. Safety and efficacy have not been established for children or adolescents, so it is not recommended for them. In elderly patients, dose adjustments should be made considering the decline of liver and kidney functions, and they should take it cautiously. In case of overdose, symptoms may appear due to low blood pressure and excessive vasodilation, requiring immediate medical attention, and blood pressure and heart function should be closely monitored. Taking this medication with grapefruit juice may increase its blood pressure-lowering effect; therefore, it is advisable to avoid it, and interactions with other drugs should be discussed with a physician or pharmacist. Store this medication in a sealed container to protect it from air and moisture. It should be kept out of the reach of children and stored away from direct sunlight.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, severe allergic reactions, serious skin reactions, jaundice, liver abnormalities, serious neurological symptoms, significantly reduced urine output, severe swelling or urinary abnormalities.

Mild side effects

• Decreased libido
• dizziness
• headaches
• orthostatic hypotension
• drowsiness
• disturbances in perception
• perceptual decline
• fainting
• lightheadedness
• heart palpitations

This medication should be stored in a sealed container protected from air and moisture. It is recommended to keep the storage temperature between 1°C and 30°C at room temperature. Proper storage like this can help maintain the drug's effectiveness for a longer period.

Appearance

White round film-coated tablet

Package unit

30 tablets (10 tablets / PTP packaging x 3)